Company intelligence / Profile preview

deltaG Ketones

Orlando, Florida, United States
Ownership
Private
Employees
~15
Development stage
Other
01

Overview

deltaG Ketones is a life sciences company that develops and commercializes a proprietary ketone ester, (R)-3-hydroxybutyl (R)-3-hydroxybutyrate, originally developed through a collaboration between the University of Oxford and the National Institutes of Health (NIH). The company's technology provides a highly efficient way to elevate blood ketone levels without the need for restrictive ketogenic diets, offering a potent fuel source for the brain and muscles. deltaG's products are used by elite athletes for performance and recovery, while the molecule is simultaneously being investigated in numerous clinical trials for therapeutic applications in metabolic, cardiovascular, and neurological health. The company focuses on bridging the gap between high-performance nutrition and medical metabolic therapy.

Therapeutic areas
OtherEndocrinologyCardiovascularNeurologyMetabolic Disorders
Modalities
Small molecule
Industry
Biotech
02

Partnerships

University of OxfordNational Institutes of HealthDARPA

Beyond the preview

Go deeper on deltaG Ketones.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on deltaG Ketones.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call